ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 145 filers reported holding ITEOS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $236,662 | -29.5% | 21,613 | -14.8% | 0.00% | – |
| Q2 2023 | $335,780 | +0.4% | 25,361 | +3.2% | 0.00% | – |
| Q1 2023 | $334,370 | +2301.2% | 24,568 | +3345.7% | 0.00% | – |
| Q4 2022 | $13,925 | -66.8% | 713 | -67.9% | 0.00% | – |
| Q3 2022 | $42,000 | -17.6% | 2,224 | -9.0% | 0.00% | – |
| Q2 2022 | $51,000 | -42.7% | 2,445 | -12.7% | 0.00% | – |
| Q1 2022 | $89,000 | -77.2% | 2,802 | -66.5% | 0.00% | – |
| Q4 2021 | $390,000 | -75.9% | 8,357 | -86.0% | 0.00% | – |
| Q3 2021 | $1,617,000 | +32240.0% | 59,901 | +27631.9% | 0.00% | – |
| Q2 2021 | $5,000 | -92.2% | 216 | -88.5% | 0.00% | – |
| Q1 2021 | $64,000 | -75.8% | 1,874 | -76.0% | 0.00% | – |
| Q4 2020 | $264,000 | +35.4% | 7,811 | -1.2% | 0.00% | – |
| Q3 2020 | $195,000 | – | 7,903 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $52,174,000 | 19.87% |
| MPM BioImpact LLC | 1,745,943 | $33,260,000 | 7.88% |
| Boxer Capital, LLC | 2,154,058 | $41,035,000 | 2.31% |
| TANG CAPITAL MANAGEMENT LLC | 937,500 | $17,859,000 | 2.19% |
| RA Capital Management | 4,417,259 | $84,149,000 | 1.80% |
| BVF INC/IL | 1,810,835 | $34,496,000 | 1.42% |
| Zebra Capital Management LLC | 12,271 | $234,000 | 0.89% |
| Integral Health Asset Management, LLC | 195,000 | $3,715,000 | 0.72% |
| Prairiewood Capital, LLC | 32,269 | $615,000 | 0.51% |
| DAFNA Capital Management LLC | 97,560 | $1,859,000 | 0.50% |